Os Therapies Inc.
OSTX
and Mission OS Therapies Incorporated ( OS Therapies, the Company, we, our or us ) is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$44M
▼ -223.7% YoY
Op. Margin
–
ROIC
-1051.44%
Cash Flow & Balance Sheet
FCF (TTM)
-$18M
▼ -101.9% YoY
Op. Cash Flow (TTM)
-$18M
▼ -95.5% YoY
Net Debt
$2M
Cash & Equiv.
$432K
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with OSTX
Os Therapies (OSTX) in two numbers
Questions about Os Therapies
Does Os Therapies (OSTX) pay a dividend?
No. Os Therapies (OSTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 13 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in OSTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing OSTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.